EXPERIENCE WITH EFFERENT METHODS USED IN THE TREATMENT OF SEVERE HYPERLIPIDEMIA IN A PREGNANT WOMAN
- Autores: FEDOROVA T.A1, ROGACHEVSKY O.V1, ORDZHONIKIDZE N.V1, TKACHEVA O.N1, MITRYA I.V1
-
Afiliações:
- Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
- Edição: Nº 2 (2012)
- Páginas: 90-92
- Seção: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246744
- ID: 246744
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Objective. To evaluate the efficiency of using plasmapheresis (PA) and cascade plasma filtration (CPF) in a pregnant woman with severe hyperlipidemia. Subjects and methods. The paper describes a clinical observation of a female patient diagnosed as having 33—34-week pregnancy, chronic placental insufficiency, decompensated type 1 diabetes mellitus, diabetic micro- and macroangiopathy, hepatic steatosis, hyperlipidemia, and chronic pyelonephritis. She was treated with 3 PA sessions on a PSA-2 device (Haemonetics, USA) and 2 CPF sessions on a Cobe Spectra apparatus (Frezenius, Germany) with an Evaflux 5a filter (Kuraray, Japan). Clinical, biochemical, hemostasiological, and ultrasound studies were used. Results. There was a significant reduction in the lipid spectrum parameters: the levels of cholesterol, triglycerides, low-density lipoproteins, and thrombodynamic potential after a course of therapeutic PA and CPF. At 36 weeks gestation, the patient gave birth to a baby by cesarean section. The boy was alive, 47 cm in length, weighed 2359 g, with Apgar scores of 7/8. Conclusion. Efferent hemocorrection techniques should be considered as the methods of choice in treating pregnant women with obvious metabolic disturbances to prevent fatal pancreatitis and severe obstetric complications.
Texto integral
Sobre autores
T. FEDOROVA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
Email: tfedorova1@mail.ru
Moscow
O. ROGACHEVSKY
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of RussiaMoscow
N. ORDZHONIKIDZE
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of RussiaMoscow
O. TKACHEVA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of RussiaMoscow
I. MITRYA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of RussiaMoscow
Bibliografia
- Коновалов Г.А., Кухарчук В.В., Покровский С.Н. Экстракорпоральные методы лечения дислипидемий // Вестн. «Медси». — 2009. — № 3. — C. 13—24.
- Кулаков В.И., Серов В.Н., Абубакирова А.М., Федорова Т.А. Интенсивная терапия в акушерстве и гинекологии (эфферентные методы). — М.: МИА, 1998.
- Макацария А.Д., Пшеничникова Е.Б., Пшеничникова Т.Б., Бицадзе В.О. Метаболический синдром и тромбофилия в акушерстве и гинекологии. — M.: МИА, 2006.
- Хаютина Т.Л., Балаболкин М.И., Коновалов Г.А. и др. Пути коррекции липидного обмена у больных сахарным диабетом 2 типа // Вестн. «Медси». — 2008. — № 2. — C. 28—43.
- Mabuchi H., Higashikata T., Kawashiri M.A. Clinical applications of long-term LDL- apheresis on and beyond refractory hypercholesterolemia // Transfus. Apher. — 2004. — Vol. 30, № 4. — P. 233—243.
- Morelli F., Carlier P., Giannini G. et al. Hypercholesterolemia and LDL apheresis // Int. J. Artif. Organs. — 2005. — Vol. 28, № 7. — P. 1025—1031.
- Sivakumaran P., Tabak S.W., Gregory K. et al. Management of familial hypertriglyceridemia during pregnancy with plasma exchange // J. Clin. Apher. — 2009. — Vol. 24, № 1. — P. 42—46.
- Szczepiorkowski Z.M., Bandarenko N., Kim H.C. et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the apheresis applications committee of the American Society for apheresis // J. Clin. Apher. — 2007. — Vol. 22, № 1. — P. 106—175.